UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

PENGARUH COGNITIVE BEHAVIOR THERAPY TERHADAP SKOR DEPRESI, SKOR MEX SLEDAI, DAN HEALTH RELATED QUALITY OF LIFE PASIEN LUPUS ERITEMATOSUS SISTEMIK

dc.contributor.advisorArina, Widya Murni,
dc.contributor.authorYESSI, APRIANCE
dc.date.accessioned2026-09-24T17:23:30Z
dc.date.issued2025-04-27
dc.descriptionDr. dr. Arina Widya Murni, SpPD-KPSi, M.Kes, FINASIM
dc.description.abstractPendahuluan : Lupus Eritematosus Sistemik (LES) adalah penyakit autoimun yang menyebabkan berbagai gangguan fisik dan psikologis, termasuk depresi. Penelitian ini mengeksplorasi efikasi Cognitive Behavior Therapy (CBT) dalam mengurangi depresi, derajat aktivitas penyakit dan meningkatkan kualitas hidup pasien LES. Ketidakcukupan data di Indonesia mengenai pengaruh terapi psikologis ini menjadikan penelitian ini penting untuk dilakukan.. Metode : Penelitian ini merupakan suatu penelitian eksperimental dengan desai pre and post control group design dilaksanakan di Instalasi Rawat Jalan Poliklilnik Khusus RSUP Dr. M. Djamil Padang. Subjek penelitian yang sesuai dengan kriteria inklusi dan eksklusi berjumlah 20 sampel masing - masing kelompok kontrol dan kelompok intervensi yang dipilih secara systematic sampling. Dilakukan intervensi Cognitive Behavior Theraphy dengan pendekatan psikoedukasi kelompok sebanyak tiga kali pertemuan interval waktu dua minggu pada kelompok intervensi, sedangkan pada kelompok kontrol hanya melanjutkan terapi medis, mengikuti kegiatan edukasi serta psikoterapi superfisial bersamaan dengan kelompok intervensi di awal pelaksanaan penelitian. Hasil : Sampel sebanyak 20 orang dari masing - masing kelompok kontrol dan kelompok intervensi, berjenis kelamin perempuan, dengan rerata umur 28,8±7,86 tahun. Terdapat perbedaan yang bermakna pada kelompok intervensi setelah CBT terhadap skor depresi (p < 0,001) dan kualitas hidup yang dinilai dengan skor Lupus QoL (p 0,02), namun tidak untuk hasil skor MEX SLEDAI (p 0,103). Didapatkan effect size CBT terhadap skor depresi dengan kekuatan efek kecil hingga sedang (Cohen’s d 0,442), skor MEX SLEDAI dengan efek kecil (Cohen’s d 0,384) dan HRQoL dengan efek sedang hingga besar (Cohen’s d 0,705) Kesimpulan: CBT berpengaruh terhadap skor depresi, derajat aktivitas penyakit dan peningkatan kualitas hidup pasien LES. Penerapan CBT sebagai salah satu tatalaksana non farmakologi pasien LES dapat dipertimbangkan.
dc.identifier.urihttps://ailib.my.id/handle/123456789/4096
dc.language.isoid
dc.publisherUNIVERSITAS ANDALAS
dc.subjectcognitive behavior therapy
dc.subjectLES
dc.subjectDepresi
dc.subjectMEX SLEDAI
dc.subjectQoL
dc.subject.classificationRC Internal medicine
dc.titlePENGARUH COGNITIVE BEHAVIOR THERAPY TERHADAP SKOR DEPRESI, SKOR MEX SLEDAI, DAN HEALTH RELATED QUALITY OF LIFE PASIEN LUPUS ERITEMATOSUS SISTEMIK
dc.typeThesis
dcterms.dateSubmitted2025-05-28
dcterms.referencesGu M, Cheng Q, Wang X, Yuan F, Sam N, Pan H, et al. The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and metaanalysis. Lupus. 2019;28(3):371–82. 2. Emrizal K, Hamijoyo L, Lidyana L. Correlation of Anxiety Disorder and Quality of Life in Systemic Lupus Erythematosus Patients. Indones J Rheumatol. 2019 3. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus : A systematic review of epidemiological studies. British society for rheumatology published by oxford press. 2017;1-17 4. Taufik A, Wachjudi RG, Hamijoyo L. Factors related to infection in systemic lupus erythematosus patients admitted to the hospital. Indonesian journal of rheumatology. 2022;14(1):588-97 5. Rekomendasi Perhimpunan Reumatologi Indonesia. Diagnosis dan pengelolaan lupus eritromatosus sistemik. Perhimpunan reumatologi indonesia. 2019 6. Velazquez ML, Highland KB. Pulmonary manifestations of systemic lupus erythematosus and sjogren’s syndrome. Wolters kluwer health Inc. 2018;30(00):1-16 7. Amarnani R, Yeoh SA, Denneny EK, Wincup C. Lupus and the lungs : The assesment and management of pulmonary manifestations of systematic lupus erythematosus. Frontiers in medicine. 2021;7(610257):1-9 8. Shen B, Tan W, Feng G, He Y, Liu J, Chen W, et al. The Correlations of Disease Activity, Socioeconomic Status, Quality of Life, and Depression/Anxiety in Chinese Patients with Systemic Lupus Erythematosus. Clin Dev Immunol. 2013:1–6 9. Narupan N, Seeherunwong A, Pumpuang W. Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand. BMC Psychiatry. 2022;22(1):103 xvi 10. Chen J, Xu T, Wu M. Depression in systemic lupus erythematosus: Modifiable or inheritable? a two-sample mendelian randomization study. Front Genet. 2022;13:988022. 11. Yoon S, Kang DH, Choi TY. Psychiatric symptoms in systemic lupus erythematosus : Diagnosis and Treatment. J Rheum Dis. 2019;26:93-103 12. Figueiredo-Braga M, Cornaby C, Cortez A, Bernardes M, Terroso G, Figueiredo M, et al. Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors. Medicine (Baltimore). 2018;97(28):e11376. 13. Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. Treasure Island (FL): StatPearls Publishing.2024 Diakses dari https://www.ncbi.nlm.nih.gov/books/NBK535405/ 14. Kouba BR, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues ALS. Role of Inflammatory mechanisms in major depressive disorder : from etiology to potential pharmacological targets.Cells.2024;13:423 15. Duca L, Roman NA, Ifteni P, Teodorescu A. One-Year Outcomes for Depression and Anxiety in SLE Patients. Biomedicines. 2024;12(3):484 16. Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, Mendoza-Pinto C, Alonso-García NE, Montiel-Jarquín A, et al. Factors Associated with HealthRelated Quality of Life in Mexican Lupus Patients Using the LupusQol. Zhou X jie, editor. PLOS ONE. 2017;12(1):e0170209 17. Touma Z (ed). Outcome Measures and Metrics in Systemic Lupus Erythematosus. Cham: Springer International Publishing.2021;12:229-49 18. Navarrete-Navarrete N, Peralta-Ramírez MI, Sabio-Sánchez JM, Coín MA, Robles-Ortega H, Hidalgo-Tenorio C, et al. Efficacy of Cognitive Behavioural Therapy for the Treatment of Chronic Stress in Patients with Lupus Erythematosus: A Randomized Controlled Trial. Psychother Psychosom. 2010;79(2):107–15 19. Akyirem S, Forbes A, Wad JL, Due-Christensen M. Psychosocial interventions for adults with newly diagnosed chronic disease: A systematic review. J Health Psychol. 2022;27(7):1753–82 20. Sakr BR, Seif EM, Kamel RM, Eleishi HH. Impact of psycho-educational therapy on disease activity, quality of life, psychological status, treatment satisfaction and xvii adherence in systemic lupus erythematosus patients. Egypt Rheumatol. 2022;44(4):313–7 21. Solati K, Mousavi M, Kheiri S, Hasanpour-Dehkordi A. The Effectiveness of Mindfulness-based Cognitive Therapy on Psychological Symptoms and Quality of Life in Systemic Lupus Erythematosus Patients: A Randomized Controlled Trial. Oman Med J. 2017;32(5):378–85. 22. Da Hora TC, Lima K, Maciel RRBT. The effect of therapies on the quality of life of patients with systemic lupus erythematosus: a meta-analysis of randomized trials. Adv Rheumatol. 2019;59(1):34. 23. O’Donohue WT, Fisher JE (ed). Cognitive behavior therapy : core principles for practice. Hoboken N.J Wiley.2012 24. Xu H, Teng Q, Zeng Y, Tian C, Yang B, Yao X. Psychoeducational Intervention Benefits the Quality of Life of Patients with Active Systemic Lupus Erythematosus. Tan S, editor. J Nanomater.2021;2021:1–8 25. Suarjana, I Nyoman. Imunopatogenesis lupus eritematosus sistemik. Dalam Setiati S, Laksmi PW (ed). Peran internis dalam tatalaksana penyakit – penyakit pada kehamilan. Jakarta : PIP Interna. 2019;3331-45 26. Arnaud L, Vollenhoven RV. Epidemiology in advanced handbook of systemic lupus erythematosus. Springer international publishing switzerland.2018 27. Bai Y, Tong Y, Liu Y, Hu H. Self-dsDNA in the pathogenesis of systemic lupus erythematosus. British Society for Immunology, Clinical and Experimental Immunology. 2017;191:1-10 28. Accapezzato D, Caccavale R, Paroli MP, Gioia C, Nguyen BL, Spadea L, Paroli M. Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. International Journal of Molecular Sciences.2023;24:1-23 29. Silbernagl S, Lang F. Color Atlas of Pathophysiology. Thieme Publishers New York.2000;52-4 30. Pereira MG, Duarte S, Ferraz A, Santos M, Fontes L. Quality of life in patients with systemic lupus erythematosus: the mediator role of psychological morbidity and disease activity. Psychol Health Med. 2020;25(10):1247–57 31. National Institute of Mental Health. Depression. Tersedia di : http//www.nimh.nih.gov/health/topics/depression. Diakses pada: 2 Maret 2024 32. Murni AW. Terapi Depresi pada Nyeri Kronis dalam Harun H, Nagara GK, Efendi YP, Citra BD, Mahatma G (ed). The 4 th Scientific Meeting On Psychosomatic xviii Medicine.2016 Mei 21-22;Bagian Ilmu Penyakit Dalam FK Universitas Andalas Padang.161-170 33. Muntigl P. Interaction in psychotherapy: managing relationships in emotionfocused treatments of depression. Cambridge, United Kingdom: Cambridge University Press; 2024 34. Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional Riskesdas 2018/Badan Penelitian dan Pengembangan Kesehatan. Jakarta:Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan.2019 35. Peng G jiang, Tian J sheng, Gao X xia, Zhou Y zhi, Qin X mei. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression. Curr Neuropharmacol. 2015;13(4):514–23 36. Kim IB, Lee JH, Park SC. The Relationship between Stress, Inflammation, and Depression. Biomedicines.2022;10(8):1929 37. Malhi GS, Mann JJ. Depression. The Lancet. 2018;392(10161):2299–312 38. Belmaker RH, Agam G. Major Depressive Disorder. N Engl J Med. 2008;358(1):55–68 39. Vashist SK, Schneider M. Depression : An insight and need for personalized psychological stress monitoring and management. Journal of Basic & Applied Sciences. 2014;10:177-82 (36) 40. Dozois DJA, Dobson KS, editors. Treatment of psychosocial risk factors in depression. Washington: American Psychological Association; 2023 41. Seet D, Allameen NA, Tay SH, Cho J, Mak A. Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management. Rheumatol Ther. 2021;8(2):651–79 42. Macêdo EA, Appenzeller S, Costallat LTL. Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS). Lupus. 2018;27(2):179–89 43. Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology. 2004;43(12):1536–40 44. Anindito B, Hidayat R, Koesnoe S, Dewiasty E. Validity And Reliability Of Lupus Quality Of Life Questionnaire In Patients With Systemic Lupus Erythematosus In Indonesia. Indones J Rheumatol.2018;8(2) xix 45. Nguyen MH, Huang FF, O’Neill SG. Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care. J Clin Med. 2021;10(16):3754 46. Nguyen LT, Alexander K, Yates P. Psychoeducational Intervention for Symptom Management of Fatigue, Pain, and Sleep Disturbance Cluster Among Cancer Patients: A Pilot Quasi-Experimental Study. J Pain Symptom Manage. 2018 Jun;55(6):1459–72 47. Karlson EW, Liang MH, Eaton H, Huang J, Fitzgerald L, Rogers MP, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004;50(6):1832–41 48. Hanna B, Hanna A. Mindfulness-based Cognitive Behavioral Therapy during Pandemic : Health Aplication. International Journal of Digital Society (IJDS).2022;13(1):1751-8 49. Elvira SD, Hadisukanto G (ed). Buku Ajar Psikiatri.Universitas Indonesia Publishing. Jakarta. 2022(3);30:429-43 50. Conceicao CTM, Meinao IM, Bombana JA, Sato EI. Psychoanalytic psychotherapy improves quality of life, depression, anxiety and coping in patients with systemic lupus erythematosus : a controlled randomized clinical trial. Advances in Rheumatology.2019:59;4 51. Fangtham M, Kasturi S, Bannuru RR, Nash JL, Wang C. Non Pharmacological therapies for systemic lupus erythematosus. Lupus.2019 52. Supratiknya A. Merancang Program dan Modul Psikoedukasi Edisi Revisi.Universitas Sanata Dharma.Yogyakarta.2011 53. Ardi Z, Eseadi C, Yuniarti E, Yendi FM, Murni AW. Efficacy of Cognitive Behavioral Therapy With Local Wisdom and Web-Based Counseling on Generalized Anxiety Disorders and Functional Gastrointestinal Disorders in Adolescent College Girls: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023;12:e50316. 54. Emorinken A, Dic-Ijiewere MO, Erameh CO, Ugheoke AJ, Agbadaola OR, Agbebaku FO, et al. Clinical and laboratory profile of systemic lupus erythematosus patients at a rural tertiary centre in South-South Nigeria: experience from a new rheumatology clinic. Reumatologia 2021; 59: 402–10 xx 55. Odunlami GJ, Ajibade A, Omotoso BA, Hassan MO, Adefidipe AA, Olanrewaju FO, et al. Clinical and Laboratory of systemic lupus erythematosus patients in a new rheumatology clinic in southwestern Nigeria. Reumatologia.2024;62(2):83-93 56. Chung MK, Park JS, Lim H, Lee CH, Lee J. Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years : A nationwide population-based study. Lupus. 2021;30(4):674-9 57. Sachdeva R, Pal R. The influence of reproductive hormones on systemic lupus erythematosus. Explor Immunol. 2022;2:351-62 58. Carrion-Nessi FS, Marcano-Rojas MV, Arocha SR, Millan DL, Forero-Pena D, Antuarez-Magallanes AW, et al. Impact of demographic, clinical and treatment compliance characteristics on quality of life Venezuelan patients with systemic lupus erythematosus. BMC Rheumatol. 2022;6:2 59. Brailovski E, Vinet E, Pineau CA, Lee J, Lukusa L, Kalache F, et al. Marital status and age of systemic lupus erythematous diagnosis: the potential for differences related to sex and gender.Lupus Science and Medicine. 2019;6:e000325 60. Ubhi M, Dubey S, Gordon C, Adizie T, Sheeran T, Allen K, et al. Undestanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK : An explorative qualitative study. Lupus. 2021;30(9):1492-1501 61. Booth S, Price E, Walker E. Fluctuation, invisibility, fatigue - the barriers to maintaining emplotment with systemic lupus erythematosus : results of an online survey. Lupus. 2018;27:2284-91 62. Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Georgios S, Sidiropoulos P, et al. High Comorbidity Burden in Patients with SLE : Data from the CommunityBased Lupus Registry of Crete. J Clin Med. 2021;10:998 63. Tsai HL, Chang JW, Lu JH, Liu CS. Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune disease : a nationwide study. Korean J Intern Med. 2022;37:864-76 64. Kim HA, Seoa L, Jung JY, Kim YW, Lee E, Cho SM, et al. Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus : A pilot study. Complementary Therapies in Clinical Practice. 2019;35:18-21 65. Fazlian M, Solati S K, Mousvi M, Ghasemi Pirbaloti M. Comparison of the Effectiveness of Cognitive Behavioral Based and Mindfulness-Based Stress Management Program on Activity, Quality of Life and Self-Efficiency of Patients xx with Systemic Lupus Erythematosus. J Adv Med Biomed Res 2018; 26 (115) :78- 91 66. Liang H, Tian X, Cao LY, Chen YY, Wang CM. Effect of psychological intervention on health-related quality of life in people with systemic lupus erythematosus : A Systematic Review. Int Journal of Nursing Sciences. 2014;1(3):298-305 67. Al-Homood IB, Omran NE, Alwahibi AS, Aldosoghy M, Alharthy A, Aljohani GS. Depression in patients with systemic lupus erythematosus : A multicenter study. Saudi Journal of Med & Med Sci. 2017 ; 593): 248 - 53 68. Sahebari M, Ebrahimabad MJA, Shoraketokanio AA, Sharbaf HA, Khodashashi M. Efficacy of Aceptance and Commitment Therapy ini Reducing Disappointment, Psychological Distress, and Psychasthenia among Systemic Lupus Erythematosus (SLE) Patients. Iran J Psychiatry. 2019;14(2):130-6 69. Fazlian M, Solati SK, Mousvi M, Pirbaloti MG. Comparison of the Effectiveness of Cognitive Behavior Based and Mindfulness-Based Stress Management Program on Activity, Quality of Life and SelfEfficiency Lupus Erythematosus. J Adv Med Biomed. 2018;26(115):78-91 70. Geertsema-Hoeve BC, Sickinghe AA, Schaik-Mast SJV, Spierings J, Laar JMV, Limper M. The effect of lifestyle interventions on disease activity and quality of life in patients with systemic lupus erythematosus : A systematic review. Elsevier. 2024;23(103609):1-11 71. Pitsillou E, Brenehan SM, Kagarakis EA, Wijoyo SJ, Liang J, Hung A, dkk. The Cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. Molecular Biology Reports. 2019
local.eprints.dirdisk0/00/49/54/94
local.eprints.divisionSPPD2024
local.eprints.id495494
local.eprints.typethesis/6Spesialis
local.eprints.urihttp://scholar.unand.ac.id/495494/
local.fakultasFakultas Kedokteran
local.identifier.nim2050302205
local.prodiSp-1 Penyakit Dalam
local.thesis.levelKarya Spesialis

Files

Collections